Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Germline variant in Ctcf links mental retardation to Wilms tumor predisposition.
Gargallo P, Oltra S, Tasso M, Balaguer J, Yáñez Y, Dolz S, Calabria I, Martínez F, Segura V, Juan-Ribelles A, Llavador M, Castel V, Cañete A, Font de Mora J. Gargallo P, et al. Among authors: font de mora j. Eur J Hum Genet. 2022 Nov;30(11):1288-1291. doi: 10.1038/s41431-022-01105-x. Epub 2022 Apr 22. Eur J Hum Genet. 2022. PMID: 35459888 Free PMC article.
Germline Predisposition to Pediatric Cancer, from Next Generation Sequencing to Medical Care.
Gargallo P, Oltra S, Yáñez Y, Juan-Ribelles A, Calabria I, Segura V, Lázaro M, Balaguer J, Tormo T, Dolz S, Fernández JM, Fuentes C, Torres B, Andrés M, Tasso M, Castel V, Font de Mora J, Cañete A. Gargallo P, et al. Among authors: font de mora j. Cancers (Basel). 2021 Oct 24;13(21):5339. doi: 10.3390/cancers13215339. Cancers (Basel). 2021. PMID: 34771502 Free PMC article.
Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1).
Bellini A, Pötschger U, Bernard V, Lapouble E, Baulande S, Ambros PF, Auger N, Beiske K, Bernkopf M, Betts DR, Bhalshankar J, Bown N, de Preter K, Clément N, Combaret V, Font de Mora J, George SL, Jiménez I, Jeison M, Marques B, Martinsson T, Mazzocco K, Morini M, Mühlethaler-Mottet A, Noguera R, Pierron G, Rossing M, Taschner-Mandl S, Van Roy N, Vicha A, Chesler L, Balwierz W, Castel V, Elliott M, Kogner P, Laureys G, Luksch R, Malis J, Popovic-Beck M, Ash S, Delattre O, Valteau-Couanet D, Tweddle DA, Ladenstein R, Schleiermacher G. Bellini A, et al. Among authors: font de mora j. J Clin Oncol. 2021 Oct 20;39(30):3377-3390. doi: 10.1200/JCO.21.00086. Epub 2021 Jun 11. J Clin Oncol. 2021. PMID: 34115544 Free PMC article.
Immunosuppressive profiles in liquid biopsy at diagnosis predict response to neoadjuvant chemotherapy in triple-negative breast cancer.
Salvador-Coloma C, Santaballa A, Sanmartín E, Calvo D, García A, Hervás D, Cordón L, Quintas G, Ripoll F, Panadero J, Font de Mora J. Salvador-Coloma C, et al. Among authors: font de mora j. Eur J Cancer. 2020 Nov;139:119-134. doi: 10.1016/j.ejca.2020.08.020. Epub 2020 Sep 29. Eur J Cancer. 2020. PMID: 32987253 Free article.
Distribution of segmental chromosomal alterations in neuroblastoma.
Juan Ribelles A, Gargallo P, Ferriol C, Segura V, Yáñez Y, Juan B, Cañada AJ, Font de Mora J, Cañete A, Castel V. Juan Ribelles A, et al. Among authors: font de mora j. Clin Transl Oncol. 2021 Jun;23(6):1096-1104. doi: 10.1007/s12094-020-02497-2. Epub 2020 Sep 18. Clin Transl Oncol. 2021. PMID: 32948984
55 results